Myomo (MYO) Total Debt (2017 - 2025)
Myomo's (MYO) quarterly Total Debt came in at $14.0 million in Q4 2025, up 24.36% YoY from $11.2 million in Q4 2024, and up 308.45% on a QoQ basis from $3.4 million in Q3 2025.
Myomo (MYO) Total Debt (2017 - 2025) Analysis & Trends
Myomo (MYO) has 5 years of Total Debt data on file, last reported at $14.0 million in Q4 2025.
- Quarterly Total Debt rose 24.36% year-over-year to $14.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.0 million (up 24.36% YoY) and the FY2025 annual result came in at $14.0 million, up 24.36% from the prior year.
- Total Debt grew to $14.0 million in Q4 2025, from $3.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $14.0 million in Q4 2025 to a low of $3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 32.61 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 14.94 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 27.96 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.62 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 10.10 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 8.68 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 1.89 Bn |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | 11.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.96 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 3.83 Mn |
| Dec 31, 2024 | 11.22 Mn |
| Jun 30, 2020 | 77,892.00 |
| Mar 31, 2020 | 1.43 Mn |
| Dec 31, 2019 | 2.65 Mn |
| Dec 31, 2017 | 750,000.00 |
| Sep 30, 2017 | 876,458.00 |
| Jun 30, 2017 | 876,458.00 |